Autologous hematopoietic stem cell transplant (aHSCT) — commonly called stem cell therapy — lessens fatigue and improves quality of life in people with highly active relapsing multiple sclerosis (MS), according to a small study in Lithuania.
These gains in the physical and social domains of quality of life were linked to a reduction in disability levels for up to two years after transplant in this study. That suggests that clinical improvements from aHSCT may drive boosts in life quality for MS patients.
The findings address a gap in knowledge about patient perspectives on the success of a stem cell transplant beyond clinical measures of MS disease severity, the researchers noted.
Read more at: https://multiplesclerosisnewstoday.com/news-posts/2022/09/16/stem-cell-transplant-improves-life-quality-life-eases-fatigue/
